These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 26257236)

  • 1. An atypical case of bilateral posterior scleritis in a patient with chronic lymphocytic leukemia.
    Soon AK; Chan TY
    Can J Ophthalmol; 2015 Aug; 50(4):e60-3. PubMed ID: 26257236
    [No Abstract]   [Full Text] [Related]  

  • 2. Long-term follow up of the CLL2007FMP trial evaluating fludarabine and cyclophosphamide in combination with either rituximab or alemtuzumab in previously untreated patients with chronic lymphocytic leukemia.
    Feugier P; Aurran T; Mahé B; Letestu R; Nguyen-Khac F; Cazin B; Tournilhac O; Maisonneuve H; Casasnovas O; Delmer A; Leblond V; Royer B; Corront B; Chevret S; Delépine R; Vaudaux S; Van Den Neste E; Béné MC; Cymbalista F; Ross-Weil D; Leprêtre S
    Haematologica; 2018 Jul; 103(7):e304-e306. PubMed ID: 29545348
    [No Abstract]   [Full Text] [Related]  

  • 3. An unusual manifestation in a patient with Neurofibromatosis type 1.
    Miraglia E; Iacovino C; Cantisani C; Calvieri S; Giustini S
    G Ital Dermatol Venereol; 2016 Feb; 151(1):129-30. PubMed ID: 26924035
    [No Abstract]   [Full Text] [Related]  

  • 4. Variations on the fludarabine, cyclophosphamide, and rituximab combination in chronic lymphocytic leukemia therapy: what have we learned?
    Ahmadi T; Schuster SJ
    J Clin Oncol; 2009 Feb; 27(4):479-80. PubMed ID: 19075263
    [No Abstract]   [Full Text] [Related]  

  • 5. Paraneoplastic pemphigus despite treatment with rituximab, fludarabine and cyclophosphamide in chronic lymphocytic leukemia.
    Schierl M; Foedinger D; Geissler K; Rappersberger K; Feldmann R
    Eur J Dermatol; 2008; 18(6):717-8. PubMed ID: 19049939
    [No Abstract]   [Full Text] [Related]  

  • 6. Point: Does Chemoimmunotherapy Still Have a Role in CLL? Chemoimmunotherapy With FCR Is Still an Important Option in CLL.
    Thompson PA; Tam CS
    Oncology (Williston Park); 2018 Jun; 32(6):291-2, 294-6. PubMed ID: 29940059
    [No Abstract]   [Full Text] [Related]  

  • 7. [Chemoimmunotherapy with fludarabine, cyclophosphamide, and rituximab].
    Tsukasaki K
    Nihon Rinsho; 2015 Feb; 73 Suppl 2():632-5. PubMed ID: 25831837
    [No Abstract]   [Full Text] [Related]  

  • 8. Changing the way we think about chronic lymphocytic leukemia.
    Lin TS; Grever MR; Byrd JC
    J Clin Oncol; 2005 Jun; 23(18):4009-12. PubMed ID: 15767640
    [No Abstract]   [Full Text] [Related]  

  • 9. Low-dose thalidomide in combination with oral fludarabine and cyclophosphamide is ineffective in heavily pretreated patients with chronic lymphocytic leukemia.
    Giannopoulos K; Dmoszyńska A; Roliński J
    Leuk Res; 2007 Mar; 31(3):411-2. PubMed ID: 16978694
    [No Abstract]   [Full Text] [Related]  

  • 10. [Modern times: back to past, back to future].
    Feliu J; Zabalza A; García-Muñoz R; Olavarría E
    Med Clin (Barc); 2012 Jul; 139(4):180-1. PubMed ID: 22281094
    [No Abstract]   [Full Text] [Related]  

  • 11. Rituximab plus fludarabine and cyclophosphamide or other agents in chronic lymphocytic leukemia.
    Robak T; Lech-Maranda E; Robak P
    Expert Rev Anticancer Ther; 2010 Oct; 10(10):1529-43. PubMed ID: 20942624
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Specific palatal infiltration in B-cell chronic lymphocytic leukemia].
    Cervigón I; Palomo A; Torres-Iglesias LM; Solano F; Zapata AM
    Actas Dermosifiliogr; 2011 May; 102(4):305-7. PubMed ID: 21354544
    [No Abstract]   [Full Text] [Related]  

  • 13. Clinical challenges in chronic lymphocytic leukemia.
    O'Brien S
    Semin Hematol; 1998 Jul; 35(3 Suppl 3):22-6. PubMed ID: 9685176
    [No Abstract]   [Full Text] [Related]  

  • 14. Pure erythroid leukemia evolving from a therapy-related myelodysplastic syndrome secondary to treatment for chronic lymphocytic leukemia.
    Sadrzadeh H; Hasserjian R; Fathi AT
    Am J Hematol; 2013 Mar; 88(3):240-1. PubMed ID: 22565525
    [No Abstract]   [Full Text] [Related]  

  • 15. Optimal First-Line Therapy for Previously Untreated Chronic Lymphocytic Leukemia: The Case for Chemotherapy.
    Brown JR
    Oncology (Williston Park); 2015 Jun; 29(6):442, 444. PubMed ID: 26091679
    [No Abstract]   [Full Text] [Related]  

  • 16. Richter syndrome: an aggressive transformation.
    Streu E
    Oncol Nurs Forum; 2015 Mar; 42(2):200-3. PubMed ID: 25806888
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In defence of the use of modern chemotherapy regimens for the treatment of patients with chronic lymphocytic leukaemia.
    Tam CS
    Intern Med J; 2009 Dec; 39(12):858-9. PubMed ID: 20233254
    [No Abstract]   [Full Text] [Related]  

  • 18. Efficacy and safety of front-line therapy with fludarabine-cyclophosphamide-rituximab regimen for chronic lymphocytic leukemia outside clinical trials: the Israeli CLL Study Group experience.
    Herishanu Y; Goldschmidt N; Bairey O; Ruchlemer R; Fineman R; Rahimi-Levene N; Shvidel L; Tadmor T; Ariel A; Braester A; Shapiro M; Joffe E; Polliack A;
    Haematologica; 2015 May; 100(5):662-9. PubMed ID: 25661442
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Does FCR have the potential to cure a subgroup of patients with chronic lymphocytic leukemia?
    Wierda WG
    Clin Adv Hematol Oncol; 2019 Apr; 17(4):214-216. PubMed ID: 31188811
    [No Abstract]   [Full Text] [Related]  

  • 20. Can FCR be curative in CLL?
    Killock D
    Nat Rev Clin Oncol; 2015 Dec; 12(12):684. PubMed ID: 26573420
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.